Download presentation
Presentation is loading. Please wait.
Published byἈριδαίος Κωνσταντόπουλος Modified over 5 years ago
1
Successful prevention of hepatitis C virus (HCV) liver graft reinfection by silibinin mono- therapy
U.P. Neumann, M. Biermer, D. Eurich, P. Neuhaus, T. Berg Journal of Hepatology Volume 52, Issue 6, Pages (June 2010) DOI: /j.jhep Copyright © Terms and Conditions
2
Fig. 1 Effect of intravenous silibinin administration on the course of hepatitis C viremia (upper panel) and aminotransferase (ALT) and bilirubin levels (lower panel) after liver transplantation. HCV RNA levels were measured by real-time PCR assay (Cobas AmpliPrep Taqman®, Roche Diagnostics, Germany); ALT and bilirubin levels are depicted as relative values of the upper limit of normal (ULN). Journal of Hepatology , DOI: ( /j.jhep ) Copyright © Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.